This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: Haplogen Gmbh, Apeiron Biologics Ag, Evotec Se. Active years: 2019-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Oxfordshire, GB (2019)
- Abingdon, GB (2021)
Company Filing History:
2 out of 2 
1 out of 15 
1 out of 1 Years Active: 2019-2021
Title: Patricia Leonie Amouzegh: Innovator in Antiviral Compounds
Introduction
Patricia Leonie Amouzegh is a notable inventor based in Abingdon, GB. She has made significant contributions to the field of antiviral research, holding a total of 3 patents. Her work focuses on developing novel compounds aimed at treating viral infections and associated diseases.
Latest Patents
Amouzegh's latest patents include innovative antiviral compounds. The first patent describes novel compounds of general formula (I), wherein Rto Rand n have specific meanings as detailed in the description and claims. These compounds are designed for treating, preventing, or ameliorating viral infections, as well as diseases associated with PLA2G16. The second patent also relates to similar antiviral compounds, emphasizing their potential in combating viral infections and related diseases.
Career Highlights
Throughout her career, Amouzegh has worked with prominent companies in the biotechnology sector, including Haplogen GmbH and Apeiron Biologics AG. Her expertise in antiviral research has positioned her as a key player in the development of therapeutic solutions.
Collaborations
Amouzegh has collaborated with notable professionals in her field, including Wolfgang Fischl and Christopher John Yarnold. These partnerships have contributed to her innovative research and the advancement of antiviral therapies.
Conclusion
Patricia Leonie Amouzegh is a distinguished inventor whose work in antiviral compounds has the potential to make a significant impact on public health. Her contributions to the field are invaluable, and her ongoing research continues to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile